Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in  Patients With Solid Cancer

CONCLUSIONS: In a large genomic tumor-profiling registry of patients with solid cancers, alterations in KRAS and STK11 were associated with an increased risk for ATE independent of cancer type. Further investigation is needed to elucidate the mechanism by which these mutations contribute to ATE in this high-risk population.PMID:37144118 | PMC:PMC10152200 | DOI:10.1016/j.jaccao.2023.01.009
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research